Onconetix (ONCO) Invested Capital (2023 - 2025)
Historic Invested Capital for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to $4.4 million.
- Onconetix's Invested Capital fell 8939.88% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year decrease of 8939.88%. This contributed to the annual value of $8.5 million for FY2024, which is 50710.14% up from last year.
- Latest data reveals that Onconetix reported Invested Capital of $4.4 million as of Q3 2025, which was down 8939.88% from $5.9 million recorded in Q2 2025.
- Over the past 5 years, Onconetix's Invested Capital peaked at $41.1 million during Q3 2024, and registered a low of -$28.7 million during Q2 2024.
- For the 3-year period, Onconetix's Invested Capital averaged around $5.9 million, with its median value being $5.9 million (2025).
- Over the last 5 years, Onconetix's Invested Capital had its largest YoY gain of 50710.14% in 2024, and its largest YoY loss of 31944.98% in 2024.
- Quarter analysis of 3 years shows Onconetix's Invested Capital stood at $1.4 million in 2023, then soared by 507.1% to $8.5 million in 2024, then plummeted by 48.94% to $4.4 million in 2025.
- Its Invested Capital stands at $4.4 million for Q3 2025, versus $5.9 million for Q2 2025 and $4.0 million for Q1 2025.